Michael Dell (Richard Drew/AP Images)
April 25, 2023 07:17 AM EDT
Deals

$200M SPAC fund­ed by bil­lion­aire Michael Dell will un­wind af­ter fail­ing to find a part­ner

Max Gelman

Senior Editor

The bio­phar­ma in­dus­try may be do­ing deals again, but SPACs are be­ing left out of the re­cent wave.

Ori­on Biotech Op­por­tu­ni­ties Corp., a blank …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Roche no longer wants to be where ‘DNA se­quenc­ing goes to die’

Trump’s HHS de­fends drug price ne­go­ti­a­tions in No­var­tis suit

First meet­ing of CDC vac­cine ad­vi­sors in the Kennedy era is post­poned

How Keymed steered the Chi­na-to-US New­Co mod­el in biotech

Trump’s picks for NIH, CMS say they’ll un­load in­dus­try in­vest­ments

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times